-
1
-
2
-
3
-
4
-
5
-
6
-
7
Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010
Veröffentlicht in BMC research notes
VolltextArtikel -
8
-
9
Canadian and US Drug Approval Times and Safety Considerations
Veröffentlicht in The Annals of pharmacotherapy
VolltextArtikel -
10
-
11
Factors Associated with Celecoxib and Rofecoxib Utilization
Veröffentlicht in The Annals of pharmacotherapy
VolltextArtikel -
12